Eli Lilly Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 1,073

-0.3%

12:45 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ron Flanigan who wrote (189)	4/30/1998 4:03:00 PM
From: Anthony Wong	Read Replies (1) of 642

Eli Lilly Shares Rated New 'Accumulate' at Banque Rothschild [note the ridiculous target price] April 29, 1998, 2:54 a.m. PT Zurich, April 29 (Bloomberg) -- Eli Lilly & Co. (LLY US) was rated new ''accumulate'' by analyst Pierre-Yves Brack at Banque Privee Edmond Rothschild. The 9-month target price is $68.00 per share. Brack expects an EPS of $1.89 in 1 998 and $2.24 in 1999 from $1.62 in 1997. He forecasts sales of $9.65 billion i n 1998 and $10.46 billion in 1999.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next